EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dipeptidyl peptidase 4 inhibitor sitagliptin decreases myocardial fibrosis and modulates myocardial insulin signaling in a swine model of chronic myocardial ischemia

Dwight D Harris iD, Sharif A Sabe iD, Mark Broadwin, Chris Stone iD, Krishna Bellam iD, Akshay Malhotra iD, M Ruhul Abid iD, Frank W Sellke

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0307922 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Dwight D Harris und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown Univ…. Hauptthemen laut MEDLINE: Sitagliptin Phosphate, Fibrosis, Dipeptidyl-Peptidase IV Inhibitors, Signal Transduction. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective Although both clinical data and animal models suggest cardiovascular benefits following administration of Dipeptidyl Peptidase 4 (DPP-4) inhibitors, the underlying mechanisms remain unclear. We therefore sought to evaluate the effect of the DPP-4 inhibitor sitagliptin on myocardial fibrosis, and insulin signaling in chronic myocardial ischemia using a swine model. An ameroid constrictor placement on the left coronary circumflex artery of thirteen Yorkshire swine to model chronic myocardial ischemia. After two weeks of recovery, swine were assigned to one of two groups: control (CON, n = 8), or sitagliptin 100mg daily (SIT, n = 5). After 5 weeks of treatment, the swine underwent terminal harvest with collection of myocardial tissue. Fibrosis was quantified using Masson’s trichrome. Protein expression was quantified by Immunoblotting. Trichrome stain demonstrated a significant decrease in perivascular and interstitial fibrosis in the SIT group relative to CON (all p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sitagliptin PhosphateFibrosisDipeptidyl-Peptidase IV InhibitorsSignal TransductionInsulinMyocardial IschemiaDisease Models, AnimalMyocardiumAnimalsSwineChronic Disease

Substanzen

Sitagliptin PhosphateDipeptidyl-Peptidase IV InhibitorsInsulin

Autor:innen und Institutionen

  • Division of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI, United States of America.

ORCID-Profile: Dwight D Harris, Sharif A Sabe, Chris Stone, Krishna Bellam, Akshay Malhotra, M Ruhul Abid

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Harris, D. D., Sabe, S. A., Broadwin, M., Stone, C., Bellam, K., Malhotra, A., Abid, M. R., & Sellke, F. W. (2024). Dipeptidyl peptidase 4 inhibitor sitagliptin decreases myocardial fibrosis and modulates myocardial insulin signaling in a swine model of chronic myocardial ischemia. PLOS ONE. https://doi.org/10.1371/journal.pone.0307922

Vancouver

Harris DD, Sabe SA, Broadwin M, Stone C, Bellam K, Malhotra A, et al. Dipeptidyl peptidase 4 inhibitor sitagliptin decreases myocardial fibrosis and modulates myocardial insulin signaling in a swine model of chronic myocardial ischemia. PLOS ONE. 2024. doi:10.1371/journal.pone.0307922

BibTeX
@article{Harris2024,
  author = {Harris, Dwight D and Sabe, Sharif A and Broadwin, Mark and Stone, Chris and Bellam, Krishna and Malhotra, Akshay and Abid, M Ruhul and Sellke, Frank W},
  title = {Dipeptidyl peptidase 4 inhibitor sitagliptin decreases myocardial fibrosis and modulates myocardial insulin signaling in a swine model of chronic myocardial ischemia},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0307922}
}
Kostenlos starten →